Theliatinib tartrate is an Orally Active EGFR Inhibitor for Esophageal Cancer Research
EGFR stands for epidermal growth factor receptor, a tyrosine kinase and transmembrane receptor protein. It primarily functions to regulate epithelial tissue development and homeostasis. Moreover, EGFR is a driver of tumors. Specifically, it is often abnormally activated and overexpressed in cancer cells (such as esophageal cancer). EGFR selectively binds...